GL1X · GenesisL1 explorer

MolNFT v1 · #37108 · protein

Dual binding modes of a novel series of dhodh inhibitors

2FQI · Dihydroorotate dehydrogenase, mitochondrial: “Dual binding modes of a novel series of dhodh inhibitors”. X-ray diffraction, 4 ligands (FMN, ORO, ILH), 3 pockets (best druggability 0.84). MolNFT v1 #37108 on GenesisL1: 3D structure…

PDB
2FQI
Type
protein
Length
362 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydroorotate dehydrogenase, mitochondrial
EC
1.3.3.1
UniProt
Q02127
Ligands
FMN, ORO, ILH, SO4
Pockets
3 · best druggability 0.84

Structure

x-ray diffraction · 1 distinct chain · 47% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydroorotate dehydrogenase, mitochondrial (EC 1.3.3.1)protein36247% helix, 16% strandQ02127

Ligands and binding sites

  • FMN · Flavin mononucleotide · ligand · chains A
  • ORO · Orotic acid · ligand · chains A
  • ILH · 2-({[2,3,5,6-tetrafluoro-3'-(trifluoromethoxy)biphenyl-4-yl]amino}carbonyl)cyclopenta-1,3-diene-1-carboxylic acid · ligand · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A
  • ACT · Acetate ion · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14210.840.9265FMN, ORO, ILH
2930.410.7820empty
3830.400.7918ACT

Compared structures

  • 2FQI · dual binding modes of a novel series of DHODH inhibitors · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.